137 results
Page 3 of 7
8-K
EX-99.1
7qhqb 60kggij9d3ff5y
1 Dec 14
Anoro® Ellipta® (umeclidinium/vilanterol) to be reimbursed in Australia for Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-99
jt84t80sqs7
17 Oct 14
Other Events
12:00am
8-K
EX-99.1
6amtqutrh
9 Jul 14
Anoro® Ellipta® (umeclidinium/vilanterol) approved in Australia for Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-10.4
h4p2nfwf
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.1
zttbk5
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.3
7ejzygg5xyz eriqa9s
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.2
5w9uu
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-10.5
gu4intbm n52s20yfji
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
8-K
EX-99
culp3rg oudpy5bz
28 Apr 14
Financial Statements and Exhibits
12:00am
8-K
EX-10.4
nt034v
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-10.1
731zzqnxa fu0
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
hogr1hl
9 Apr 14
Regulation FD Disclosure
12:00am
8-K
EX-99
wcbwjj7u
6 Feb 14
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
wggwx64xey53s t0hby
9 Jan 14
ANORO™ ELLIPTA™ approved for COPD treatment in Canada
12:00am